Peptide Reports

GHK-Cu

Community Protocol

GHK-Cu

Reconstitution examples, syringe conversion and community-reported usage patterns.

Educational and calculation-reference material only. Community reports are uncontrolled anecdotes and do not replace professional medical guidance, product labeling, or individualized clinical monitoring.

Scope

Reconstitution examples, syringe conversion and community-reported usage patterns.

Available strengths: 50 MG and 100 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

SetupDiluentConcentrationUnit conversion
50 MG vial exampleAdd 2.5 mL bacteriostatic water20 mg/mLEach U-100 unit = 0.20 mg
100 MG vial exampleAdd 3.0 mL bacteriostatic water33.33 mg/mLEach U-100 unit = about 0.333 mg

Syringe Conversion

Reported amount50 MG setup100 MG setup
0.5 mg2.5 units1.5 units
1 mg5 units3 units
2 mg10 units6 units
3 mg15 units9 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring reportFrequency seenContext in reports
0.5-1 mgDaily or near-dailyLower-start reports
2 mgDaily or 5 days/weekMost recurring amount reviewed
Above 2 mgDaily in some postsHighly variable, less consistent

Observations

  • Across the reviewed discussions, 1-2 mg was the most repeated daily amount.
  • Six-to-eight-week runs appeared in multiple discussions, but cycle structure was not consistent.
  • Contributors repeatedly warned that syringe units are meaningless without vial strength and diluent volume.

Caveats

  • Injection-site burning or irritation was frequently discussed; severity and mitigation reports varied.
  • Copper balance and zinc supplementation were discussed by users, but online community claims are not a substitute for laboratory monitoring or clinician guidance.

Sources

  1. r/PeptideGuide, GHK-Cu dosage
  2. r/Peptidesource, GHK-CU dosing
  3. r/Peptidesource, dosing and reconstitution